Metadata |
datasetIdentifier | PASS01330 |
datasetType | SRM |
submitter | Axel Ducret <axel.ducret@roche.com> |
submitter_organization | Roche Pharmaceutical Research and Early Development |
lab_head_full_name | Andreas Tebbe |
lab_head_email | andreas.tebbe@evotec.com |
lab_head_organization | Evotec (München) GmbH |
lab_head_country | Germany |
datasetTag | 5-pr_FF_lumretuzumab |
datasetTitle | SRM validation set for the 5-protein signature predictive for lumretuzumab in cell lines and PDX (3 responders, 3 non-responders), fresh-frozen |
publicReleaseDate | 2019-03-08 00:00:00 |
finalizedDate | 2019-02-03 07:34:17 |
summary | |
contributors | Axel Ducret, Ian James, Sabine Wilson, Martina Feilke, Andreas Tebbe, Nikolaj Dybowski, Sarah Elschenbroich, Martin Klammer, Adele Blackler, Wei-Li Liao, Yuan Tian, Thomas Friess, Birgit Bossenmaier, Gabriele Dietmann, Christoph Schaab, Todd Hembrough, Maurizio Ceppi |
publication | Axel Ducret, Ian James, Sabine Wilson, Martina Feilke, Andreas Tebbe, Nikolaj Dybowski, Sarah Elschenbroich, Martin Klammer, Adele Blackler, Wei-Li Liao, Yuan Tian, Thomas Friess, Birgit Bossenmaier, Gabriele Dietmann, Christoph Schaab, Todd Hembrough, Maurizio Ceppi, Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial, PLOSOne, submitted. |
growth | |
treatment | |
extraction | |
separation | |
digestion | |
acquisition | |
informatics | |
instruments | Thermo Scientific TSQ Vantage Quantum |
species | human |
massModifications | none |